These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34955041)

  • 21. [Clinicopathological characteristics of gastric SMARCA4-deficient undifferentiated/rhabdoid carcinoma].
    Wu JY; Jiang K; Yan LJ; Yin LS; Huang XZ; Jia L; Sun Y
    Zhonghua Bing Li Xue Za Zhi; 2023 May; 52(5):447-453. PubMed ID: 37106285
    [No Abstract]   [Full Text] [Related]  

  • 22. SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1
    Agaimy A; Fuchs F; Moskalev EA; Sirbu H; Hartmann A; Haller F
    Virchows Arch; 2017 Nov; 471(5):599-609. PubMed ID: 28555282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent updates in thoracic SMARCA4-deficient undifferentiated tumor.
    Nambirajan A; Jain D
    Semin Diagn Pathol; 2021 Sep; 38(5):83-89. PubMed ID: 34147303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial rhabdoid tumour 'avant la lettre'--from pathology review to exome sequencing and back again.
    Witkowski L; Lalonde E; Zhang J; Albrecht S; Hamel N; Cavallone L; May ST; Nicholson JC; Coleman N; Murray MJ; Tauber PF; Huntsman DG; Schönberger S; Yandell D; Hasselblatt M; Tischkowitz MD; Majewski J; Foulkes WD
    J Pathol; 2013 Sep; 231(1):35-43. PubMed ID: 23775540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytology of SMARCA4-Deficient Thoracic Neoplasms: Comparative Analysis of SMARCA4-Deficient Non-Small Cell Lung Carcinomas and SMARCA4-Deficient Thoracic Sarcomas.
    Nambirajan A; Dutta R; Malik PS; Bubendorf L; Jain D
    Acta Cytol; 2021; 65(1):67-74. PubMed ID: 32854100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression.
    Hasselblatt M; Gesk S; Oyen F; Rossi S; Viscardi E; Giangaspero F; Giannini C; Judkins AR; Frühwald MC; Obser T; Schneppenheim R; Siebert R; Paulus W
    Am J Surg Pathol; 2011 Jun; 35(6):933-5. PubMed ID: 21566516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SWI/SNF-deficient undifferentiated/rhabdoid carcinoma of the gallbladder carrying a POLE mutation in a 30-year-old woman: a case report.
    Gerber TS; Agaimy A; Hartmann A; Habekost M; Roth W; Stenzinger A; Schirmacher P; Straub BK
    Diagn Pathol; 2021 Jun; 16(1):52. PubMed ID: 34118935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SWI/SNF complex-deficient soft tissue neoplasms: An update.
    Schaefer IM; Hornick JL
    Semin Diagn Pathol; 2021 May; 38(3):222-231. PubMed ID: 32646614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No small surprise - small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour.
    Foulkes WD; Clarke BA; Hasselblatt M; Majewski J; Albrecht S; McCluggage WG
    J Pathol; 2014 Jul; 233(3):209-14. PubMed ID: 24752781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A BAFfling liver aspirate: Metastatic high grade SMARCA4 deficient undifferentiated gastroesophageal junction carcinoma masquerading as a hematolymphoid malignancy.
    Kilic AI; Mirza K; Mehrotra S; Pambuccian SE
    Diagn Cytopathol; 2019 Jul; 47(7):725-732. PubMed ID: 30897306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dedifferentiated liposarcoma composed predominantly of rhabdoid/epithelioid cells: a frequently misdiagnosed highly aggressive variant.
    Agaimy A; Michal M; Hadravsky L; Michal M
    Hum Pathol; 2018 Jul; 77():20-27. PubMed ID: 29307627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rhabdoid tumor predisposition syndrome.
    Sredni ST; Tomita T
    Pediatr Dev Pathol; 2015; 18(1):49-58. PubMed ID: 25494491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gastric SWI/SNF-complex deficient undifferentiated/rhabdoid carcinoma: a clinicopathological study].
    Wang L; Tan C; Ni SJ; Jiang WH; Xu J; Cai X; Huang D; Sheng WQ; Chang B
    Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):632-637. PubMed ID: 34078052
    [No Abstract]   [Full Text] [Related]  

  • 34. SWI/SNF-deficient head and neck neoplasms: An overview.
    Agaimy A; Bishop JA
    Semin Diagn Pathol; 2021 May; 38(3):175-182. PubMed ID: 33663878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant undifferentiated and rhabdoid tumors of the gastroesophageal junction and esophagus with SMARCA4 loss: a case series.
    Gupta S; Noona SW; Pambuccian SE; Robinson B; Martin LW; Williams E; Stelow EB; Raghavan SS
    Hum Pathol; 2023 Apr; 134():56-65. PubMed ID: 36549598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens.
    Herpel E; Rieker RJ; Dienemann H; Muley T; Meister M; Hartmann A; Warth A; Agaimy A
    Ann Diagn Pathol; 2017 Feb; 26():47-51. PubMed ID: 28038711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinicopathological features of gastric alpha-fetoprotein-producing adenocarcinoma with SWI/SNF complex deletion].
    Yang JZ; Guo XX; Xu C; Hou YY; Yuan W
    Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):52-57. PubMed ID: 38178747
    [No Abstract]   [Full Text] [Related]  

  • 38. SMARCA4-Mutated Atypical Teratoid/Rhabdoid Tumor with Retained BRG1 Expression.
    Masliah-Planchon J; Machet MC; Fréneaux P; Jourdain A; Mortemousque I; Raïs KA; Ballet S; Jouvet A; Figarella-Branger D; Delattre O; Bourdeaut F
    Pediatr Blood Cancer; 2016 Mar; 63(3):568-9. PubMed ID: 26469284
    [No Abstract]   [Full Text] [Related]  

  • 39. Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2:
    Chan-Penebre E; Armstrong K; Drew A; Grassian AR; Feldman I; Knutson SK; Kuplast-Barr K; Roche M; Campbell J; Ho P; Copeland RA; Chesworth R; Smith JJ; Keilhack H; Ribich SA
    Mol Cancer Ther; 2017 May; 16(5):850-860. PubMed ID: 28292935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SMARCA4 / BRG1 -deficient Uterine Neoplasm With Hybrid Adenosarcoma and Carcinoma Features: Expanding the Molecular-morphologic Spectrum of SMARCA4 -driven Gynecologic Malignancies.
    Wei CH; Sadimin E; Agulnik M; Yost SE; Longacre TA; Fadare O
    Int J Gynecol Pathol; 2024 Jul; 43(4):354-361. PubMed ID: 38113031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.